Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

Richard Sheer,1 Kyle D Null,2 Keith A Szymanski,2 Lavanya Sudharshan,1 Jennifer Banovic,2 Margaret K Pasquale1 1Comprehensive Health Insights, Inc., Louisville, KY, 2Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA Purpose: Clinical guidelines recommend febuxostat as first-line pharmacologic...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheer R (Author), Null KD (Author), Szymanski KA (Author), Sudharshan L (Author), Banovic J (Author), Pasquale MK (Author)
Format: Book
Published: Dove Medical Press, 2017-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available